l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Rheumatoid Arthritis

l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine has been researched along with Rheumatoid Arthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goto, M; Kanbayashi, N; Naito, K; Nakajima, S; Okuyama, A	1

Other Studies

1 other study(ies) available for l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Rheumatoid Arthritis

Article	Year
Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-L-valine]. Agents and actions, 1993, Volume: 39, Issue:3-4 Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cell Survival; Cells, Cultured; Dipeptides; Endopeptidases; Female; Humans; Male; Metalloendopeptidases; Middle Aged; Protease Inhibitors; Succinates; Synovial Fluid; Tumor Cells, Cultured	1993

Article

Year

Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-L-valine].

Agents and actions, 1993, Volume: 39, Issue:3-4

Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Cell Survival; Cells, Cultured; Dipeptides; Endopeptidases; Female; Humans; Male; Metalloendopeptidases; Middle Aged; Protease Inhibitors; Succinates; Synovial Fluid; Tumor Cells, Cultured

1993